You are on page 1of 1

Gene therapy

Gene therapy was first conceptualized in 1972, with the authors urging caution before commencing gene therapy studies in humans. The first FDA-approved gene therapy experiment in the United [1] States occurred in 1990, when Ashanti DeSilva was treated forADA-SCID. Since then, over 1,700 [2] clinical trials have been conducted using a number of techniques for gene therapy. Although early clinical failures led many to dismiss gene therapy as over-hyped, clinical successes since 2006 have bolstered new optimism in the promise of gene therapy. These include successful treatment of [3][4][5][6] [7] patients with the retinal disease Leber's congenital amaurosis, X-linked SCID, ADA[8] [9] [10] SCID, adrenoleukodystrophy, chronic lymphocytic leukemia (CLL), acute lymphocytic [11] [12] [13] leukemia (ALL), multiple myeloma andParkinson's disease. These recent clinical successes have led to a renewed interest in gene therapy, with several articles in scientific and popular publications calling for continued investment in the field

You might also like